Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02540434 · ClinicalTrials.gov registry record · NA
Trial of RiaSTAP Versus Cryoprecipitate to Lower Operative Transfusions
A NA study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT02540434 is a NA study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 19 participants.
The verdict
NCT02540434, a NA study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The study aligns with the strategic plan of New York-Presbyterian Hospital (NYPH) to reduce allogeneic blood product use and decrease unnecessary laboratory costs. One of the NYPH Quality and Patient Safety Goals for 2013 was to improve the appropriate use of transfusion guidelines and reduce unnecessary red blood cell (RBC) transfusions. Further, this study will help to answer whether RiaSTAP is a more effective product to treat bleeding than cryoprecipitate. In addition, this trial will provide investigators with preliminary data to apply for future federal funding opportunities, such as the National Heart Lung and Blood Institute sponsored R21 grant (PAR-13-025) that encourages research grant applications from investigators who propose to study research topics in blood banking and transfusion medicine aimed at improving the safety and availability of the blood supply and the practice of transfusion medicine. The investigators anticipate future follow-on studies further investigating fibrinogen concentrate and other similar therapeutics in other perioperative populations, such as in postpartum hemorrhage or surgical ICU settings. Finally, this study involves the use of a safer therapeutic, fibrinogen concentrate, to improve patient care and patient safety. This product does not require the time-intensive process of thawing; therefore, delays in patient care can be avoided by having the product readily available in the OR.
Interventions
- DRUG RiaSTAP
- DEVICE ROTEM
- OTHER Cryoprecipitate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02540434
The ClinicalTrials.gov registry entry for NCT02540434 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which RiaSTAP is the first listed.
NCT02540434 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02540434 about?
NCT02540434 is a clinical study titled "Trial of RiaSTAP Versus Cryoprecipitate to Lower Operative Transfusions". The study aligns with the strategic plan of New York-Presbyterian Hospital (NYPH) to reduce allogeneic blood product use and decrease unnecessary laboratory costs. One of the NYPH Quality and Patient Safety Goals for 2013 was to improve the appropriate use of transfusion guidelines and reduce unnece...
What is the current status of trial NCT02540434?
This trial is currently terminated. It is a NA study. The enrollment target is 19 participants. The study started on 2015-10. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02540434?
The interventions under investigation include: RiaSTAP (DRUG), ROTEM (DEVICE), Cryoprecipitate (OTHER).
Who is sponsoring clinical trial NCT02540434?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.